Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
dagUCHmshdNFMDjE
Français